ALIMONTI, ANDREA

ALIMONTI, ANDREA  

Dipartimento di Medicina - DIMED  

Mostra records
Risultati 1 - 20 di 105 (tempo di esecuzione: 0.056 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
18-month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis]. 2006 ALIMONTI, ANDREA REUMATISMO - -
[Intra-articular treatment with Hylan G-F 20 under ultrasound guidance in hip osteoarthritis. Clinical results after 12 months follow-up]. 2005 ALIMONTI, ANDREA REUMATISMO - -
[Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip]. 2004 ALIMONTI, ANDREA REUMATISMO - -
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours 2015 COZZA, GIORGIORUZZENE, MARIAAlimonti, Andrea + NATURE COMMUNICATIONS - -
A man with a deltoid swelling and paraneoplastic erythrocytosis: case report 2003 ALIMONTI, ANDREA ANTICANCER RESEARCH - -
A multidisciplinary approach for the identification and validation of novel prostate cancer targets - ABSTRACTS OF THE 40TH CONGRESS OF THE ITALIAN PHARMACOLOGICAL SOCIETY (SIF) 2021 Federico GianfantiAndrea AlimontiMonica Montopoli + PHARMADVANCES - -
A new mathematical model based on clinical and laboratory variables for the diagnosis of Sjögren's syndrome. 2003 ALIMONTI, ANDREA CLINICAL RHEUMATOLOGY - -
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. 2010 ALIMONTI, ANDREA THE JOURNAL OF CLINICAL INVESTIGATION - -
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. 2009 ALIMONTI, ANDREA NATURE GENETICS - -
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events. 2008 ALIMONTI, ANDREA GENES & DEVELOPMENT - -
Aging tumour cells to cure cancer: Pro-senescence" therapy for cancer 2017 ALIMONTI, ANDREA + SWISS MEDICAL WEEKLY - -
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) 2020 Montopoli, MZumerle, SVettor, RRugge, MZorzi, MRagazzi, EAlimonti, A + ANNALS OF ONCOLOGY - -
Anti-senescence activity of Salvia haenkei on skin cellular model identified by integrated senescence-screening assay 2017 Jessica CadauVeronica CocettaStefano Dall'AcquaEugenio RagazziMonica MontopoliAndrea Alimonti + PIANTE MEDICINALI - -
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer 2023 Montopoli, MonicaAlimonti, Andrea + CANCER CELL - -
B7-H3 as a Therapeutic Target in Advanced Prostate Cancer 2022 Bianca Calı`Andrea AlimontiSilvia Bressan + EUROPEAN UROLOGY - -
Can colorectal cancer patients with thymidylate synthase-overexpressing liver metastases have an overall survival advantage with hepatic arterial infusion alone? 2003 ALIMONTI, ANDREA JOURNAL OF CLINICAL ONCOLOGY - -
Can the reliance of hormone receptor assays of surgical specimens be explained by the fluctuation of estrogen receptor, progesterone receptor, and HER-2 protein expression in tumor samples of premenopausal breast cancer patients? 2005 ALIMONTI, ANDREA JOURNAL OF CLINICAL ONCOLOGY - -
Can we also treat hip osteoarthritis with intra-articular injections of hialuronic acid? Clinical results of 2 year experience using ultrasound guided intra-articular injections 2003 Alimonti A. + GAZZETTA MEDICA ITALIANA. ARCHIVIO PER LE SCIENZE MEDICHE - -
CD38 in Advanced Prostate Cancers 2021 Alimonti, Andrea + EUROPEAN UROLOGY - -
CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression 2023 Alimonti, Andrea + SCIENTIFIC REPORTS - -